Developed in partnership between the Pediatric and Congenital Page et al 2015 ACC/AHA/HRS SVT Guideline e567 Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Heart Rhythm. 2012;9:1006 24. 413. Dixon J, Foster K, Wyllie J, et al. Guidelines and adenosine dosing in supraventricular tachycardia. Arch Dis Child. 2005;90:1190 1. 414. D az-Parra S, S nchez-Ya ez P, Zabala-Arg elles I, et al. Use of adenos- ine in the treatment of supraventricular tachycardia in a pediatric emer- gency department. Pediatr Emerg Care. 2014;30:388 93. 415. Losek JD, Endom E, Dietrich A, et al. Adenosine and pediatric supraven- tricular tachycardia in the emergency department: multicenter study and review. Ann Emerg Med. 1999;33:185 91. 416. Sanatani S, Potts JE, Reed JH, et al. The study of antiarrhythmic medi- cations in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants. Circ Arrhythm Electrophysiol. 2012;5:984 91. 417. Deal BJ, Keane JF, Gillette PC, et al. Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and fol- low-up. J Am Coll Cardiol. 1985;5:130 5. 418. Villain E, Bonnet D, Acar P, et al. [Recommendations for the treat- ment of recurrent supraventricular tachycardia in infants]. Arch Pediatr. 1998;5:133 8. 419. Fish FA, Gillette PC, Benson DW Jr. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. J Am Coll Cardiol. 1991;18:356 65. 420. Lee P-C, Hwang B, Chen S-A, et al. The results of radiofrequency cath- eter ablation of supraventricular tachycardia in children. Pacing Clin Electrophysiol. 2007;30:655 61. 421. Van Hare GF, Javitz H, Carmelli D, et al. Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomes. J Cardiovasc Electrophysiol. 2004;15:759 70. 422. Aiyagari R, Saarel EV, Etheridge SP, et al. 